Results 91 to 100 of about 515,071 (299)

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Human vaccines and immunotherapeutics: News September 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News March 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

R&D and Patenting Activity and the Propensity to Acquire in High Technology Industries [PDF]

open access: yes
In this paper we investigate the incidence of high technology acquisitions using a large international sample of acquisitions by public high technology firms.
Alan Hughes, Panayotis Dessyllas
core  

Impact of Acquisitions on CEO pay [PDF]

open access: yes, 2012
I examine the impact of acquisition on the pay of CEOs of S&P 1500 firms from 1994-2010. I find insignificant effect of firm performance on post-acquisition CEO pay. Controlling for firm size, CEOs are paid a premium in post-acquisition pay.
Homroy, Swarnodeep
core  

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

open access: yesMolecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee   +8 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News May 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Human vaccines & immunotherapeutics: News November 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

Home - About - Disclaimer - Privacy